Legal fight on finasteride between MSD Korea and Choong-wae Pharm gets into full swing

Published: 2003-12-18 07:00:00

Updated: 2003-12-18 07:00:00

The legal battle between MSD Korea and Choong-wae Pharm has begun, as a local court plans to convene a hearing on a request for an injunction against the production and marketing of Finastar (finasteride), benign prostatic hyperplasia therapy and generic version of Proscar, by the latter firm.
...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK